Holen Sie sich die Stockscreener-App
6.11
1.30%
-0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLDB?
Forum
Prognose
Aktiensplit
Solid Biosciences Inc Aktie (SLDB) Neueste Nachrichten
Solid Biosciences’ SWOT analysis: promising DMD gene therapy stock faces pivotal year - Investing.com
Citi Maintains Buy Rating on Solid Biosciences with $16 Price Target - AInvest
Citizens JMP Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
J.P. Morgan Sticks to Their Buy Rating for Solid Biosciences (SLDB) - The Globe and Mail
SLDB’s Stock Market Adventure: -9.49% YTD Growth Amidst Volatility - investchronicle.com
JMP reiterates Market Outperform rating on Solid Biosciences stock By Investing.com - Investing.com Canada
Can Solid Biosciences Inc. recover in the next quarter2025 Growth vs Value & Weekly Market Pulse Updates - Newser
40,930 Shares in Solid Biosciences Inc. (NASDAQ:SLDB) Purchased by XTX Topco Ltd - Defense World
Solid Biosciences (NASDAQ:SLDB) Shares Up 9.9% Following Strong Earnings - Defense World
Smart tools for monitoring Solid Biosciences Inc.’s price actionWeekly Volume Report & Weekly High Conviction Ideas - Newser
Is Solid Biosciences Inc. stock overhyped or has real potentialOptions Play & Real-Time Market Sentiment Alerts - Newser
Why Solid Biosciences Inc. stock attracts strong analyst attention2025 Trading Recap & Capital Efficiency Focused Ideas - Newser
Developing predictive dashboards with Solid Biosciences Inc. data2025 Price Targets & Long-Term Capital Growth Strategies - Newser
What institutions are buying Solid Biosciences Inc. stock nowJuly 2025 Action & Fast Momentum Stock Entry Tips - Newser
Wedbush Maintains Solid Biosciences(SLDB.US) With Buy Rating, Cuts Target Price to $14 - 富途牛牛
William Blair Maintains Buy Rating for Solid Biosciences, Raises Price Target to $15.44. - AInvest
A Quick Look at Today's Ratings for Solid Biosciences(SLDB.US), With a Forecast Between $10 to $20 - 富途牛牛
Solid Biosciences: Promising Developments and Financial Stability Drive Buy Rating - TipRanks
Solid Biosciences Reports Increased Assets Amid Ongoing Losses - TipRanks
How Solid Biosciences Inc. stock performs during market volatilitySecure Entry Point Finder with Analysis - Newser
Solid Biosciences shares rise 2.81% after-hours following Anixa Biosciences' patent extension to 2045. - AInvest
SOLID BIOSCIENCES Earnings Results: $SLDB Reports Quarterly Earnings - Quiver Quantitative
Solid Biosciences Pushes Forward Despite Growing Losses - Finimize
Solid Biosciences Q2 net loss widens to $39.5 mln - MarketScreener
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Solid Biosciences Inc. Reports Progress in Clinical Trials and Financial Highlights for Q2 2025 - Quiver Quantitative
How to read the order book for Solid Biosciences Inc.Market Forecast Summary Over Multi-Year Period - Newser
Applying big data sentiment scoring on Solid Biosciences Inc.Momentum Prediction Based on AI Backtesting - Newser
Risk adjusted return profile for Solid Biosciences Inc. analyzedStock Market Watch with Smart Filters - Newser
Solid Biosciences Inc. stock trend forecastFree Earnings Play Trade Plan With Alerts - Newser
Wyckoff Accumulation Phase Possible in Solid Biosciences Inc.Breakout Momentum Picks With Protection Outlined - beatles.ru
Key resistance and support levels for Solid Biosciences Inc.Volume Confirmed Setup with Entry Confidence - Newser
Solid Biosciences (SLDB) Projected to Post Quarterly Earnings on Tuesday - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of “Buy” from Analysts - Defense World
Solid Biosciences SLDB 2025Q2 Earnings Preview Upside Potential on Strategic Developments - AInvest
Will Solid Biosciences Inc. rebound enough to break evenPrice Movement and Market Sentiment Analysis - Newser
Applying Elliott Wave Theory to Solid Biosciences Inc.Chart Pattern Recognition for Profit Timing - Newser
Solid Biosciences Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView
How hedge fund analytics apply to Solid Biosciences Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Allianz Asset Management GmbH Purchases Shares of 27,100 Solid Biosciences Inc. (NASDAQ:SLDB) - Defense World
Solid Biosciences Inc. shares rise 1.03% after-hours following Wall Street's recovery from jobs report-fueled losses. - AInvest
What is the dividend policy of Solid Biosciences Inc. stockGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Solid Biosciences Inc. stock in 2025Discover stocks with massive upside potential - Jammu Links News
How strong is Solid Biosciences Inc. company’s balance sheetGet daily expert analysis for smarter investing - Jammu Links News
What are the latest earnings results for Solid Biosciences Inc.Robust investment performance - Jammu Links News
Is Solid Biosciences Inc. stock overvalued or undervaluedAchieve rapid returns with smart investment plans - Jammu Links News
What catalysts could drive Solid Biosciences Inc. stock higher in 2025Track top-performing stocks effortlessly - Jammu Links News
What drives Solid Biosciences Inc. stock priceConsistent double returns - Jammu Links News
Solid Biosciences Inc. Stock Analysis and ForecastIdentify undervalued stocks poised to rally - Jammu Links News
What makes Solid Biosciences Inc. stock price move sharplyBuild a diversified portfolio for risk management - Jammu Links News
What are Solid Biosciences Inc. company’s key revenue driversMaximize returns with data-driven strategies - Jammu Links News
When is Solid Biosciences Inc. stock expected to show significant growthDiscover undervalued stocks before they soar - Jammu Links News
What institutional investors are buying Solid Biosciences Inc. stockAchieve superior capital gains with smart trades - Jammu Links News
Solid Biosciences shares fall 2.78% after-hours following inducement grants announcement. - AInvest
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Solid Biosciences Strengthens Team with 55,450 RSU Grants for Key Genetic Medicine Experts - Stock Titan
Solid Biosciences reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
0.07%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):